Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
暂无分享,去创建一个
S. Engelborghs | I. Tesseur | J. Streffer | M. Boada | A. Börjesson-Hanson | N. Andreasen | L. Tritsmans | M. Timmers | J. Matías‐Guiu | M. Baquero | A. Russu | L. van Nueten | A. Shiraishi | H. Shimizu | Y. Tominaga | Kanaka Tatikola | P. Smekens